期刊文献+

关节炎疼痛对大鼠脊髓促炎性细胞因子的影响 被引量:1

Effect of arthritic pain on the content of IL-1β and TNF-α of the lumbar spinal cord in arthritis rats
下载PDF
导出
摘要 目的观察关节炎疼痛对大鼠脊髓促炎性细胞因子IL-1β和TNF-α水平的影响。方法Wistar大鼠20只,150~180g,雌雄各半,随机分为对照组和实验组。对照组右后踝关节腔注射生理盐水,实验组左后踝关节腔注射完全弗氏佐剂,制备单发佐剂性关节炎动物模型。4周后用屈关节疼痛试验评分法测定关节炎疼痛行为学变化,取腰段脊髓,ELISA法测定脊髓中IL-1β和TNF-α含量。结果实验组屈关节疼痛试验评分较对照组明显降低(P<0.01),IL-1β和TNF-α水平较对照组明显升高(P<0.01)。结论关节炎疼痛时脊髓IL-1β和TNF-α水平升高,提示脊髓促炎性细胞因子与关节炎疼痛的病理生理机制有关。 [Objective] To investigate effect of arthritic pain on the levels of proinflammatory cytokine IL-1β and TNF-α in the lumbar spinal cord of arthritis rats. [Methods] 20 Wistar rats were randomly divided into control group (n =10) and experimental group (n =10). The arthritis model was done by administered CFA into joint cavity of the rats in experimental group. Saline was administered into joint cavity of rats in the control group. Pain behaviors, i.e. the leg-withdrawal response scores, were measured with arthritic flexion pain test four weeks after CFA. The levels of IL-1β and TNF-α in lumbar spinal cord the fourth week after adjuvant-induced arthritis. [Result] The legwithdrawal scores in inflammed leg were significantly lower in experiment group than that in control group (P 〈0.01). Both IL-1β and TNF-α in the lumbar spinal cord were higher signifieandy in experiment group than those in control group (P 〈0.01). [Conclusion] IL-1β and TNF-α in spinal cord of the rats in adjuvant-induced arthritis were markedly increased. It is suggested that there is a correlation between IL-1β and TNF-α in spinal cord and chronic arthritic pain.
出处 《中国医学工程》 2006年第5期456-458,共3页 China Medical Engineering
关键词 关节炎疼痛 IL-1Β TNF-Α arthritis pain IL-1β TNF-α
  • 相关文献

参考文献4

二级参考文献13

  • 1王友京,王双坤.不同强度和频率电针的镇痛效应[J].针刺研究,1993,18(1):44-47. 被引量:41
  • 2刘红香,许伟,罗非,王金树,韩济生.改进的大鼠单发佐剂性关节炎模型的建立和实验观察[J].中国疼痛医学杂志,1996,2(4):223-228. 被引量:26
  • 3BLOT L. Effects of diclofenac, aceclofenae and meloxicam on the metabolism of proteoglycans and hyaluronin in osteoarthritic human cartilage[J]. Br J Pharmcol, 2000, 131(7): 1413-1421.
  • 4ZERBINI CA, MARQUES GC, GONCALVES H, et al. A multicenter study of the efficacy and tolerability of aceclofenac in the treatment of rheumatoid disease(arthritis)[J]. Rev Bras Med, 1997,54(10): 855-851.
  • 5贺联印 粟占国.类风湿关节炎的自身免疫异常及研究进展[J].复星诊断,2003,1:12-12.
  • 6HINZ B, RAU T, AUGE D, et al. Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to dielofenae[J]. Clin Phannacol Ther, 2003, 74(3): 222-235.
  • 7REN G Y. Internal Medicine[M]. Beijing:. People's Medical Publishing House, 2004:1.
  • 8LEGRAND E. Aceclofenac in the management of inflammatory pain[J]. Expert Opin Pharmacother, 2004, 5(6): 1347-1357.
  • 9PERIS F, BIRD H A, SERNI U, et al. Treatment compliance and safety of aceclofenac versus NSAIDs in patients with common arthritis disorders: a meta-analysis[J]. Eur J Rheumatol Inflamm, 1966, 6(1): 37-45.
  • 10Bai L,中国药理学报,1997年,18卷,377页

共引文献72

同被引文献23

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部